Beckman Coulter Showcases Cutting-Edge Innovations in Diagnostics

At the 2025 edition of Medlab Middle East, Beckman Coulter is showcasing the DxC 500i integrated clinical chemistry and immunoassay analyzer that incorporates DxC 500 AU chemistry analyzer technology with Six Sigma performance. Utilizing Beckman Coulter’s common reagents and consumables across its scalable clinical chemistry and immunoassay portfolio, the DxC 500i Analyzer enables commutable patient results, offering hospitals and healthcare networks strategic benefits in patient care and inventory management. The DxC 500i Clinical Analyzer features FlexMode operations, prioritizing immunoassay and chemistry testing according to each sample's urgency. The new dynamic sample handler manages repeats and re-runs without operator intervention and pulls in a new sample rack as soon as the previous rack is offloaded, optimizing rapid throughput in a compact footprint. Of equal importance, the DxC 500i’s intuitive interface supports even the newest users through proactive task indicators, step-by-step instructions and simplified staff onboarding and training.

Beckman Coulter is also highlighting the award-winning DxI 9000 immunoassay analyzer which sets a new standard with first-of-its-kind high-sensitivity immunoassay testing capabilities for the core labs. Featuring meaningful innovations, this high-throughput immunoassay analyzer takes diagnostics to the next level. Its novel, patented machine vision technology utilizes multiple cameras with defined algorithms to detect and notify users of processing errors in real time, triggering course correction right away. In addition to advancing diagnostics capabilities, the DxI 9000 excels in improving clinical laboratory operations. ZeroDaily Maintenance highlights the embedded innovations that drive the DxI 9000 Analyzer’s uptime performance. Beta users attest to ZeroDaily Maintenance redefining their workday with no daily maintenance requirements, thereby reducing annual maintenance routines by up to 96%.